Harold Manley

Nephrology pharmacist; comprehensive medication management via collaboration is best; opinions are my own

[Cristina Popa 🦋 @NephroSeeker]

Drug Dosing in Kidney
Diseases and Dialysis: Factors That Affect Drug Clearance

By Linda Awdishu

@hswapnil moderating

#kidneywk

[Nayan Arora,MD @captainchloride]

ACEi/ARBs appear to preserve residual kidney function in dialysis patients by about 1 mL/min, which has been associated with a 15-25% reduction in annual mortality #kidneywk

[Erin McCreary @ErinMcCreary]

thank you @PaulSaxMD @CIDJournal for the opportunity to share my "voice". this was intensely emotional to revisit, 'the greatest thing I've ever done that I hope to never have to do again'. loved celebrating how far we've come at #IDWeek2023
https://t.co/aPb1Jg4PJ5

[Harold Manley @harold_manley]

@Rasheeda_HallMD Awesome news. Congratulations!!

[Conrad Fischer @SeeFisch]

Dialysis patient?
Sensitive Staph in blood?
You can SAFELY give cefazolin three times a week after dialysis

[ASN Kidney360 @ASNKidney360]

"Nephrologists are required to step out of their comfort zones in tertiary centers and build partnerships with various stakeholders in the community." This article summarizes a discussion with leaders in nephrology on the issue of access to CKD care https://t.co/HCg8vsK3dl

[James Deardorff @wjdeardorff]

"The Maelstrom of Medications—Optimization of Prescribing During the Course of Dementia" (JAMA IM 2023) - "In dementia, multimorbidity is the norm, and polypharmacy is exceedingly common" - https://t.co/uY4U16uKu2

[Jithu Kurian🇮🇳 @Jithukurian6]

🔥 Let’s discuss about Chronic Kidney Disease - Mineral Bone disease (CKD- MBD)

🔥 This is what I thought it was as a student… I was wrong ❌

🔥Did you also think so ? #NephTwitter #MedTwitter #Medpearls

[NDT @NDTsocial]

🤩Good morning #NephTwitter!
Let’s discuss the management of heart failure in patients with kidney disease!
👋I am @HDiniz_ and I will guide you through the latest evidence from the ESC guidelines and beyond.
🧵6 min read👇👇👇

[Edgar V. Lerma 🇵🇭 @edgarvlermamd]

.@goKDIGO has updated the 2012 Clinical Practice Guideline for the Evaluation & Management of CKD #Nephpearls

✅ The KDIGO 2023 CKD Guideline is now available for public review Kindly submit your feedback no later than Monday, July 24th 🗓️

https://t.co/S8ya3Np1Hn

[B. Wagner, M.D. 🇺🇸 @Wagner_Nephro]

Acute kidney injury associated with nephrotoxic drugs in critically ill patients: a multicenter cohort study using electronic health record data.

In 92,616 ICU admissions, 15% developed acute kidney injury.

Iodinated contrast didn’t make the cut.

https://t.co/67GnDd71LP

[Harold Manley @harold_manley]

@AJKDonline Another avoidable medication related admission.

[Harold Manley @harold_manley]

@Teknofiliac My take: Not having a pharmacist as part of IDT.

[#NephsWhoLead @DaVitaDoc]

Our @DaVitaResearch team wants to hear from you, #NephsWhoLead: Vote on the research you want to see next. The intent of our program is to ensure our medical directors' voice is heard and interests are reflected in the work we do. Where should we focus? https://t.co/eMEFXJs6jR

[Kenar Jhaveri @kdjhaveri]

Kidney News @kidneynews 2023 June issue https://t.co/Zd606eonbX Nudging toward Progress: The State of Clinical Decision Support in Nephrology Kyle D. O'Connor and @fperrywilson @girish_nadkarni @jam_hirsch @ASNKidney

[AKHOMM @kidneymedmgmt]

Happy #NationalNursesDay! 🩺 Today we recognize the incredible role nurses play as part of the health care team in the lives of patients, especially those with kidney disease.

#TwitteRX #pharmacists #AKHOMM #NephTwitter #nephrologynurse #nursepractitioner #nephrology

[Renal Interventions @Renal_Ints]

A lack of proper training for clinicians is among the factors holding back wider adoption of peritoneal #dialysis despite its offer of greater patient freedom, says @frank_dor (London, UK).

#renalcare #vascularaccess #haemodialysis
https://t.co/uDhiNUZhzU

[American Geriatrics Society @AmerGeriatrics]

Today, @AmerGeriatrics released the 2023 update to the AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults (DOI: 10.1111/jgs.18372). https://t.co/yM4mQsCjnf

[IdoAmitLab @IdoAmitLab]

We're thrilled to share our recent @NatureMedicine study, cracking the decades-old mystery surrounding the identity of cells responsible for producing erythropoietin (Epo) - the key regulator of erythropoiesis and oxygen homeostasis in our bodies. https://t.co/bIYC0QiirB (1/16)